Natco Pharma Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled to be held on February 14, 2017, inter alia, to consider the following items of business:
1. The unaudited financial Results for the quarter ended December 31, 2016 (Q3) and related matters.
2. To consider second Interim Dividend, if any, for the financial year 2016-17 and related matters etc.
Further, pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015 TRADING WINDOW for dealing in the securities of the Company will be closed from February 03, 2017 to February 16, 2017 (both days inclusive). Trading window will be opened from February 17, 2017.
Ask Value Research 
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
